Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM.

N Engl J Med. 2000 Nov 30;343(22):1603-7.

2.
3.

Screening for colorectal cancer: current status in Japan.

Saito H.

Dis Colon Rectum. 2000 Oct;43(10 Suppl):S78-84. Review.

PMID:
11052482
4.

Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN.

Ann Intern Med. 2002 Jul 16;137(2):132-41. Review.

PMID:
12118972
5.

Fecal occult blood testing: clinical value and limitations.

Simon JB.

Gastroenterologist. 1998 Mar;6(1):66-78. Review.

PMID:
9531118
6.

Colorectal cancer screening.

Mandel JS.

Cancer Metastasis Rev. 1997 Sep-Dec;16(3-4):263-79. Review.

PMID:
9433639
7.

Is FOB screening really the answer for lowering mortality in colorectal cancer?

Autier P, Boyle P, Buyse M, Bleiberg H.

Recent Results Cancer Res. 2003;163:254-63; discussion 264-6. Review.

PMID:
12903860
8.

Fecal occult blood screening--trial evidence, practice and beyond.

Rennert G.

Recent Results Cancer Res. 2003;163:248-53; discussion 264-6. Review.

PMID:
12903859
9.

Colorectal cancer screening and follow-up.

Declan Fleming RY.

Surg Oncol. 1998 Nov-Dec;7(3-4):125-37. Review.

PMID:
10677164
10.

[Topics of colorectal-cancer screening and surveillance].

Hirata I.

Nihon Shokakibyo Gakkai Zasshi. 2007 Jul;104(7):987-93. Review. Japanese. No abstract available.

PMID:
17611374
11.

[Primary and secondary prevention of colorectal tumors].

Yoshida Y.

Nihon Naika Gakkai Zasshi. 1995 Sep 10;84(9):1380-7. Review. Japanese. No abstract available.

PMID:
8537738
12.

Early diagnosis for colorectal cancer in China.

Zhang YL, Zhang ZS, Wu BP, Zhou DY.

World J Gastroenterol. 2002 Feb;8(1):21-5. Review.

Supplemental Content

Support Center